41 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
or at the election of the participant, in a manner that complies with Section 409A of the Code. A participant has no voting rights with respect to any RSU … , have a dilutive effect on earnings per share and on stockholders’ equity and voting rights. Furthermore, future sales of substantial amounts of our
424B5
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Prospectus supplement for primary offering
4:53pm
including with respect to dividends and voting rights. Upon exercise of the pre-funded warrants, the holders will be entitled to exercise the rights … not have the rights or privileges of a holder of our common stock, including any voting rights, until the holder exercises the pre-funded warrant.
S
424B5
gqe0j4snc93d
1 May 23
Prospectus supplement for primary offering
4:06pm
8-K/A
EX-99.3
nzz95lhaf ycw8bnckw
30 Nov 22
Financial Statements and Exhibits
6:46pm
425
3fbsf51fmp47nggtg
15 Sep 22
Business combination disclosure
4:08pm
8-K
EX-99.1
5crp32pyqw3fdc1glr8
15 Sep 22
Departure of Directors or Certain Officers
4:06pm
424B3
e55b3qn4vin37s2
8 Aug 22
Prospectus supplement
5:47pm
S-4
zuuwvtjghh5n5y
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
S-4
EX-10.5
opor1s56fdrz aa131fg
18 Jul 22
Registration of securities issued in business combination transactions
7:58am